DelveInsight’s “Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Typhoid Fever, epidemiology insights, Typhoid Fever market trends, therapies and key companies working in the Typhoid Fever Market in the 7MM.
Typhoid Fever Overview
Typhoid fever is a bacterial infection that can spread throughout the body, affecting many organs. Without prompt treatment, it can cause serious complications and can be fatal. It’s caused by a bacterium called Salmonella typhi, which is related to the bacteria that cause salmonella food poisoning.
Typhoid Fever Epidemiology Insights
According to Van Leung-Pineda (2019), the prevalence of Typhoid Fever in the US is approximately 1 in 35,000, with two-thirds having symptoms in the neonatal period. The mortality rate of Typhoid Fever is 24% in neonatal cases and 11% in later onset cases.
According to Mageed G (2015), the prevalence of Typhoid Fever in EU-4 was 1.89 per 100,000 in the 0-4-year-old age group, 1.63 per 100,000 in the 10-14-year-old age group, and 1.57 per 100,000 in the 15-17-year-old age group.
The clinical manifestations are variable. The most severe type is neonatal-onset UCD, which occurs within 28 days after birth and is characterized by vomiting, food refusal, lethargy, tachypnea, impaired consciousness, and multiorgan failure.
According to Batshaw et al. (2014), the mortality rate of UCD is 24% in neonatal onset cases and 11% in late-onset cases.
Click here to learn more about the Typhoid Fever Market Landscape
The Report Covers the Typhoid Fever Epidemiology Segmented by:
Typhoid Fever incident cases
Typhoid Fever diagnosed cases
Typhoid Fever treatment cases
Typhoid Fever onset-specific cases
Typhoid Fever Market Outlook
The Typhoid Fever market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Typhoid Fever market trends by analyzing the impact of current Typhoid Fever therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. This segment gives a thorough detail of the Typhoid Fever market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. According to DelveInsight, the Typhoid Fever market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Typhoid Fever Market
AcerTherapeutics
Aeglea BioTherapeutics
Ultragenyx Pharmaceutical
And many others
Typhoid Fever Therapies Covered and Analyzed in the Report:
ACER-001
AEB1102
DTX301
Learn more about the Key Companies and Emerging Therapies in the Typhoid Fever Market
Table of Contents
Key Insights
Typhoid Fever Introduction
Executive Summary of Typhoid Fever
Disease Background and Overview
Epidemiology and patient population
Typhoid Fever Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Typhoid Fever Market Outlook
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services